Beijing Bans Sale Of Four Medicines
May 25, 2009 |
Print
|
Email
|
Comments | Category: Health, Law & Order
Beijing is banning the sale of four kinds of medicine which are alleged to be the subject of misleading claims.
It is learned that the promoters of these medicines were accused of cheating and misleading consumers by overstating their efficacy.
The four medicines are reported in local media to be Ganbifu Soft Capsules, Wuwei Tongshuan Koufuye, Kang Shou Wan, and Fufang Shousen Yizhi Capsules. There is no word yet on what penalties the makers of these pharmaceuticals could face.
Find more stories about: advertising, Beijing, drugs, Fufang Shousen Yizhi Capsules, Ganbifu Soft Capsules, Kang Shou Wan, medicine, pharmaceutical, Wuwei Tongshuan Koufuye
Leave A Comment:
Inside ChinaCSR.com
-
Education
- HTC Chairman Sets Up New Charitable Foundation
- American Medical Company Plans Physician Training With New Beijing Outpost
- Chinese Universities Sign Education Deals With Christian American School
- New "100,000 Strong Initiative" Hopes To Build U.S.-China Golden Bridges
- Best Buy Creates Education Fund In China
-
Energy & Cleantech
-
Environment
-
Giving
-
Happenings
-
Health
- Legal Action Against Counterfeit Cigarettes In America Could Impact Chinese Makers
- New Collaboration In China Aims To Provide Low-cost Medicines
- Carrefour's Beijing Stores Gain Green Market Certification
- American Medical Company Plans Physician Training With New Beijing Outpost
- New Healthcare Chief Named For GE China
-
Labor
-
Law & Order
-
Viewpoints
- Companies Can Help In The March Towards Better Consumer Rights In China
- CSR Review: Companies Have More Opportunities To Develop In China
- How Far Can Chinese Companies Take Corporate Social Responsibility?
- CSR Review: Companies Focus On Sustainability In China During Downturn
- Global Financial Woes May Impact Corporate Social Responsibility In China







